Khartis Therapeutics
5 known investors
Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. It operates in the biopharmaceutical and therapeutics sector.
Investors · 5
Funding
SEC filings, press & company announcements$95M disclosed across 1 of 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Khartis bags USD 95m for oral challenger to Tepezzaallsci.com · Aug 2026
Khartis Therapeutics Emerges from Stealth with $95 Million in Funding to Advance Oral Small Molecule Immunology Pipeline - BioSpacebiospace.com · Aug 2026
StreetInsider.com - Khartis Therapeutics Emerges from Stealth with $95 Million in Funding to Advance Oral Small Molecule Immunology Pipelinemarkets.financialcontent.com · Aug 2026
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillfiercebiotech.com · Aug 2026Frequently asked questions
- What does Khartis Therapeutics do?
- Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. It operates in the biopharmaceutical and therapeutics sector.
- Who are Khartis Therapeutics's investors?
- Khartis Therapeutics's investors include Foresite Capital, Nextech Invest, Alexandria, Lilly Asia Ventures, Longwood Fund.
- How much funding has Khartis Therapeutics raised?
- Khartis Therapeutics has disclosed $95M raised across 1 of its 2 known rounds.